母胎医学会咨询系列第71号:不可存活期与围存活期早产前胎膜破裂的管理
本咨询系列针对不可存活期与围存活期早产前胎膜破裂的管理提出7条推荐。核心包括:所有患者均应接受个体化咨询并获得终止妊娠选择,无禁忌时可提供期待治疗(GRADE 1C);孕≥24 0/7周选择期待治疗者推荐使用抗生素(GRADE 1B),孕20 0/7至23 6/7周可考虑抗生素(GRADE 2C);在医疗团队认为适合且患者希望尝试新生儿复苏和重症监护之前,不推荐产前使用糖皮质激素和硫酸镁(GRADE 1B)。系列羊膜腔灌注和羊膜补片被视为研究性手段,仅限临床试验使用(GRADE 1B)。宫颈环扎可在讨论风险获益并共享决策后拆除或保留(GRADE 2C);后续妊娠按既往自发性早产指南管理(GRADE 1C)。
要点
- 所有不可存活期/围存活期早产前胎膜破裂患者均应接受个体化咨询,告知终止妊娠与期待治疗的母胎风险获益,并提供终止妊娠选择(GRADE 1C)。
- 孕≥24 0/7周选择期待治疗者推荐使用抗生素(GRADE 1B);孕20 0/7至23 6/7周可考虑抗生素(GRADE 2C)。
- 在医疗团队认为适合且患者希望尝试新生儿复苏和重症监护之前,不推荐产前使用糖皮质激素和硫酸镁(GRADE 1B)。
- 系列羊膜腔灌注和羊膜补片被视为研究性手段,仅限临床试验使用,不推荐用于常规管理(GRADE 1B)。
- 宫颈环扎可在讨论风险获益并共享决策后拆除或保留(GRADE 2C);后续妊娠按既往自发性早产指南管理(GRADE 1C)。
适用人群与场景
- 不可存活期与围存活期早产前胎膜破裂的孕妇,即尚未到医疗团队认为适合且患者希望尝试新生儿复苏和重症监护的孕周阶段。
处置流程与药物剂量
- 所有不可存活期/围存活期早产前胎膜破裂患者均应接受个体化咨询,告知终止妊娠与期待治疗的母胎风险获益,以指导知情决策;所有患者均应获得终止妊娠选择,无禁忌时可提供期待治疗(GRADE 1C)。
- 孕≥24 0/7周选择期待治疗者推荐使用抗生素(GRADE 1B)。
- 孕20 0/7至23 6/7周可考虑使用抗生素(GRADE 2C)。
- 在医疗团队认为适合且患者希望尝试新生儿复苏和重症监护之前,不推荐产前使用糖皮质激素和硫酸镁(GRADE 1B)。
- 宫颈环扎管理:讨论风险获益并共享决策后,拆除或保留宫颈环扎均合理(GRADE 2C)。
- 后续妊娠有不可存活期/围存活期早产前胎膜破裂史者,推荐遵循既往自发性早产的管理指南(GRADE 1C)。
研究设计与关键结果
- 母胎医学会发布咨询系列第71号,针对不可存活期与围存活期早产前胎膜破裂提出7条推荐,采用GRADE分级(1C、1B、2C、1B、1B、2C、1C)。
证据类型、等级与局限
- 证据类型:指南(母胎医学会咨询系列);推荐强度与证据等级采用GRADE分级,逐条标注为1C、1B、2C、1B、1B、2C、1C。
- 局限:原文未报告局限性
对床旁实践的改变
- 对不可存活期/围存活期早产前胎膜破裂患者,应提供个体化咨询,告知终止妊娠与期待治疗的母胎风险获益,并提供终止妊娠选择(GRADE 1C)。
- 孕≥24 0/7周选择期待治疗者推荐使用抗生素(GRADE 1B);孕20 0/7至23 6/7周可考虑抗生素(GRADE 2C)。
- 在医疗团队认为适合且患者希望尝试新生儿复苏和重症监护之前,不推荐产前使用糖皮质激素和硫酸镁(GRADE 1B)。
- 系列羊膜腔灌注和羊膜补片被视为研究性手段,仅限临床试验使用,不推荐用于常规管理(GRADE 1B)。
- 宫颈环扎可在讨论风险获益并共享决策后拆除或保留(GRADE 2C)。
指南或共识出处
- 母胎医学会咨询系列第71号:不可存活期与围存活期早产前胎膜破裂的管理(Society for Maternal-Fetal Medicine Consult Series #71),发表于American Journal of Obstetrics and Gynecology。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Previable and periviable preterm prelabor rupture of membranes are challenging obstetrical complications to manage given the substantial risk of maternal morbidity and mortality, with no guarantee of fetal benefit. The following are the Society for Maternal-Fetal Medicine recommendations for the management of previable and periviable preterm prelabor rupture of membranes before the period when a trial of neonatal resuscitation and intensive care would be considered appropriate by the healthcare team and desired by the patient: (1) we recommend that pregnant patients with previable and periviable preterm prelabor rupture of membranes receive individualized counseling about the maternal and fetal risks and benefits of both abortion care and expectant management to guide an informed decision; all patients with previable and periviable preterm prelabor rupture of membranes should be offered abortion care, and expectant management can also be offered in the absence of contraindications (GRADE 1C); (2) we recommend antibiotics for pregnant individuals who choose expectant management after preterm prelabor rupture of membranes at ≥24 0/7 weeks of gestation (GRADE 1B); (3) antibiotics can be considered after preterm prelabor rupture of membranes at 20 0/7 to 23 6/7 weeks of gestation (GRADE 2C); (4) administration of antenatal corticosteroids and magnesium sulfate is not recommended until the time when a trial of neonatal resuscitation and intensive care would be considered appropriate by the healthcare team and desired by the patient (GRADE 1B); (5) serial amnioinfusions and amniopatch are considered investigational and should be used only in a clinical trial setting; they are not recommended for routine care of previable and periviable preterm prelabor rupture of membranes (GRADE 1B); (6) cerclage management after previable or periviable preterm prelabor rupture of membranes is similar to cerclage management after preterm prelabor rupture of membranes at later gestational ages; it is reasonable to either remove the cerclage or leave it in situ after discussing the risks and benefits and incorporating shared decision-making (GRADE 2C); and (7) in subsequent pregnancies after a history of previable or periviable preterm prelabor rupture of membranes, we recommend following guidelines for management of pregnant persons with a previous spontaneous preterm birth (GRADE 1C).
参考来源
- Battarbee AN, Osmundson SS, McCarthy AM, et al. Society for Maternal-Fetal Medicine Consult Series #71: Management of previable and periviable preterm prelabor rupture of membranes. Am J Obstet Gynecol. 2024. PMID: 39025459. doi:10.1016/j.ajog.2024.07.016
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。